Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease.

Developing the model structure through an explicit process of model conceptualization can increase the transparency and accuracy of results. We will populate the conceptual model with the data sources described and evaluate the cost-effectiveness of curative therapies.